Feedback / Questions
risvodetinib (ABLi-148009) - ABLi Therapeutics
http://clinicaltrials.gov/ct2/show/NCT05424276
Nov 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next